Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
Shopping Cart: ( empty )
You are here: Home > Journals > SH > SH07088
RESEARCH ARTICLE
Contents Vol 5(1)

Syncope as a probable side effect to combination antiretroviral therapy initiated during primary HIV-1 infection

Dorte Lybaek A B and Carsten Schade Larsen A
+ Author Affiliations
- Author Affiliations

A Department of Infectious Diseases, Skejby Hospital, University Hospital of Aarhus, DK-8200 Aarhus N, Denmark.

B Corresponding author. Email: dlybaek@dadlnet.dk

Sexual Health 5(1) 69-71 https://doi.org/10.1071/SH07088
Submitted: 2 November 2007  Accepted: 22 January 2008   Published: 22 February 2008

Abstract

A previously healthy young man experienced several episodes of syncope while being treated with tenofovir, emtricitabine and nevirapine initiated during primary HIV-1 infection. Symptoms disappeared after discontinuation of antiretroviral therapy and we suggest that syncope may be a side effect to one of the three antiretroviral drugs that has not been described previously.


References


[1] Kinloch-de Loes S. Treatment of acute HIV-1 infection: is it coming of age? J Infect Dis 2006; 194 721–4.
| Crossref | GoogleScholarGoogle Scholar | PubMed | [verified February 2008].

[3] van Leth F,  Phanuphak P,  Ruxrungtham K,  Baraldi E,  Miller S,  Gazzard B, et al. Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study. Lancet 2004; 363 1253–63.
| Crossref | GoogleScholarGoogle Scholar | PubMed | [verified February 2008]. Abstract 124LB.

[13] Koegl C , Wolf E , Jessen H , Schewe K , Rausch M , Goelz J , et al No benefit from early treatment in primary HIV-infection? 14th Conference on Retroviruses and Opportunistic Infections; 2007 Feb 25–28; Los Angeles, CA, USA. CROI 2007. Available online at: http://www.retroconference.org/2007/abstract [verified February 2008]. Abstract 125LB.

[14] Hammer SM,  Saag MS,  Schechter M,  Montaner JSG,  Schooley RT,  Jacobsen DM, et al. Treatment for adult HIV infection. 2006 recommendations of the International AIDS Society-USA panel. JAMA 2006; 296 251–65.
| Crossref | GoogleScholarGoogle Scholar |

[15] Bartlett JG , Lane HC , Pau AK , Anderson J , Baker AC , Bozzette SA , et al Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV; October 2006: 1–121. Department Health and Human Services.

[16] Gazzard B on behalf of the BHIVA writing Committee. British HIV association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). HIV Med 2006; 7 487–503.
| Crossref | GoogleScholarGoogle Scholar | PubMed |